Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Related Party Transaction

10 Mar 2022 07:00

RNS Number : 2721E
Maven Income and Growth VCT 5 PLC
10 March 2022
 

MAVEN INCOME AND GROWTH VCT 5 PLC

LEI: 213800DMF84841RMWX35

9 March 2022

Related Party Transaction

 

Maven Income and Growth VCT 5 PLC (the "Company") announces that, following a review and taking into account peer group analysis, the Company's administrative and secretarial fee and performance fee arrangements with the Company's investment manager, Maven Capital Partners UK LLP ("Maven"), have changed.

 

With effect from 1 December 2021, the annual administrative and secretarial fee payable to Maven will be increased from £86,000, to £100,000, payable quarterly in arrears and subject to an annual adjustment, calculated on 1 December each year.

 

Maven will continue to be entitled to a performance fee on a revised basis with effect from 1 December 2021 should certain criteria be met. The updated key terms of the calculation of the performance fee are summarised below:

§ the performance fee in respect of private equity investments has been increased to 15 per cent.; and

§ the performance fee in respect of the Company's quoted portfolio is now payable on all quoted investments (excluding any investment trusts).

Maven has agreed to decrease the cap on the total expenses payable by the Company from 3.25 per cent. to 3.0 per cent. of the Company's net assets per annum, adjusted annually and excluding performance fees and exceptional costs.

 

Under the Listing Rules of the FCA, a related party includes the investment manager of a closed-ended investment fund. Maven is therefore a related party of the Company under the Listing Rules and the increase in the fees payable by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

 

The Board's agreement to change the administrative and secretarial fee and the performance fee payable to Maven is a smaller related party transaction as defined in LR11.1.10R.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Company Secretary

 

9 March 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKCBPDBKBFNK
Date   Source Headline
25th Mar 20194:09 pmRNSStatement re Offer for Subscription
13th Mar 201912:12 pmRNSTransaction in Own Shares
7th Mar 20195:50 pmRNSIssue of Equity
4th Mar 201912:40 pmRNSNet Asset Value(s)
28th Feb 20195:42 pmRNSAnnual Financial Report
20th Feb 201912:30 pmRNSStatement re Offer for Subscription
15th Jan 20194:17 pmRNSTransaction in Own Shares
11th Jan 20193:50 pmRNSHolding(s) in Company
21st Dec 20181:00 pmRNSDirector/PDMR Shareholding
21st Dec 201810:39 amRNSIssue of Equity
18th Dec 20184:17 pmRNSNet Asset Value
5th Nov 20184:52 pmRNSTransaction in Own Shares
2nd Nov 201811:38 amRNSResult of General Meeting
10th Oct 20185:06 pmRNSTransaction in Own Shares
8th Oct 20184:48 pmRNSTransaction in Own Shares
5th Oct 20184:04 pmRNSTransaction in Own Shares
4th Oct 20183:03 pmRNSTransaction in Own Shares
3rd Oct 20187:00 amRNSNet Asset Value(s)
26th Sep 20186:29 pmRNSStatement re Offer for Subscription
24th Jul 20184:58 pmRNSTransaction in Own Shares
20th Jul 20182:56 pmRNSHalf-year Report
18th Jul 20189:21 amRNSNet Asset Value(s)
18th Jul 20187:00 amRNSStatement re Offer for Subscription
2nd May 20184:59 pmRNSHolding(s) in Company
25th Apr 20184:39 pmRNSNet Asset Value(s)
24th Apr 20181:34 pmRNSResult of AGM
12th Mar 20187:15 amRNSHolding(s) in Company
12th Mar 20187:00 amRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
27th Feb 20184:02 pmRNSTransaction in Own Shares
13th Feb 20183:39 pmRNSTransaction in Own Shares
25th Jan 20185:01 pmRNSTransaction in Own Shares
23rd Jan 20185:23 pmRNSTransaction in Own Shares
17th Jan 20182:46 pmRNSNet Asset Value(s)
3rd Jan 20182:00 pmRNSForm 8.3 - Plant Impact PLC
30th Nov 20174:42 pmRNSTransaction in Own Shares
29th Nov 20174:40 pmRNSTransaction in Own Shares
25th Oct 20173:05 pmRNSDividend Declaration
29th Sep 20174:01 pmRNSNet Asset Value(s)
23rd Aug 20174:50 pmRNSTransaction in Own Shares
23rd Aug 20177:00 amRNSTransaction in Own Shares
22nd Aug 20177:00 amRNSHalf-year Report
10th Aug 20174:11 pmRNSNet Asset Value and Interim Dividend
31st May 20174:58 pmRNSTransaction in Own Shares
16th May 20173:57 pmRNSTransaction in Own Shares
11th May 20172:03 pmRNSTransaction in Own Shares
25th Apr 20172:14 pmRNSResult of AGM
25th Apr 20172:12 pmRNSNet Asset Value and Proposed Final Dividend
6th Mar 20176:12 pmRNSAnnual Financial Report
6th Mar 20176:04 pmRNSCorrective Statement re Proposed Final Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.